Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Iris.ai is a private enterprise AI software company that builds tools for scientific text understanding, knowledge management, and agentic retrieval-augmented generation workflows. The company originally focused on helping R&D teams navigate scientific literature and patents, and now positions itself as an AI knowledge foundation for regulated enterprises. Its core offerings include RSpace, a secure AI research platform for ingesting, indexing, filtering, summarizing, and extracting insights from large document collections, and Neuralith, an infrastructure layer for designing, deploying, and scaling tailored agentic AI systems. Iris.ai serves organizations in sectors such as biotech, materials, manufacturing, telecom, and the public sector rather than developing therapeutics itself. For a biotech analyst, the company is best understood as a commercial AI platform vendor supporting research and innovation workflows, not as a drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Iris.ai.